arrow
N

Nobumasa Mizuno

Yamaguchi University
H指数:55
被引数:1.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Randomized phase III trial of gemcitabine plus nab-paclitaxel versus gemcitabine plus S-1 as neoadjuvant chemotherapy for resectable pancreatic cancer in geriatric patients: JCOG2101C (PRESTIGE study)

老年可切除胰腺癌患者新辅助化疗的吉西他滨联合nab-紫杉醇对比吉西他滨联合S-1的随机III期试验:JCOG2101C(PRESTIGE研究)

2026-07-010
PRE
Role of tumor markers before or during chemotherapy for digestive neuroendocrine carcinomas as an exploratory analysis of JCOG1213

消化神经内分泌癌化疗前或化疗期间肿瘤标志物的角色:JCOG1213的探索性分析

2026-04-160
OAAI
High E2F7 Expression Indicates Pancreatic Cancer Aggressiveness and Downregulation of E2F7 Enhances Sensitivity to S-1

E2F7高表达提示胰腺癌侵袭性,且E2F7下调增强对S-1的敏感性

2025-12-260
OAAI
IgG4-related disease in the Japanese population: a whole-genome sequencing study

IgG4相关性疾病在日本人群中的研究:一项全基因组测序研究

2025-11-030
PRE
Impact of ERCC1 on the outcomes of chemotherapy in advanced biliary tract cancer

ERCC1对晚期胆道癌化疗效果的影响

2025-09-300
OA
Comparison of clinical features by primary site in patients with biliary tract cancer who received gemcitabine-based chemotherapy: an exploratory analysis of JCOG1113

根据原发部位比较接受吉西他滨为基础化疗的胆道癌患者的临床特征:JCOG1113的探索性分析

2025-07-240
OA
5-Fluorouracil metabolic pathway genes predict recurrence risk following adjuvant S-1 therapy: Results of an ancillary analysis from a phase III trial of resected biliary tract cancer (JCOG1202A1)
2024-09-250
PRE
GnP vs mFOLFIRINOX or S-IROX in metastatic pancreatic cancer: 1-year follow-up updated data from the GENERATE (JCOG1611)

GnP与mFOLFIRINOX或S-IROX在转移性胰腺癌中的应用:GENERATE(JCOG1611)1年随访更新数据

2024-09-011
PRE
Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer

循环肿瘤DNA中BRCA和ATM突变状态在晚期胰腺癌治疗选择中的临床应用

2024-08-280
PRE
Development of a nomogram to predict survival in advanced biliary tract cancer

预测晚期胆道癌生存率的列线图的开发

2023-12-060
OAAI
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)

改良FOLFIRINOX与吉西他滨联合nab-紫杉醇治疗局部晚期胰腺癌的随机II期研究 (JCOG1407)

2023-03-0135
OAAI
Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer
2023-02-1310
PRE